Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells - PubMed (original) (raw)

PMID: 3023810

Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells

J H Brown et al. Mol Pharmacol. 1986 Dec.

Abstract

Carbachol is 100 times more potent for inhibiting cyclic AMP formation than for stimulating phosphoinositide (PI) hydrolysis in chick heart cells. To determine whether this reflects differences in agonist affinity of the receptor(s) coupled to the two responses, we measured these functional responses following removal of receptor reserve with propylbenzilycholine mustard (PrBCM). Conditions of PrBCM treatment that led to progressive loss of up to 95% of the [3H]-N-methylscopolamine-binding sites decreased the potency but not the maximal capacity of carbachol to inhibit cyclic AMP formation. In contrast, there was a marked decrease in the maximal PI response to carbachol. The KA for carbachol, calculated by measuring functional responses following receptor inactivation, was similar whether the cyclic AMP or the PI response was examined. These KA values (approximately 40 microM) were similar to the KD calculated by examining carbachol competition for [3H]-N-methylscopolamine-binding sites on the intact cell. PrBCM treatment also decreased the maximal effect of oxotremorine on cyclic AMP formation under conditions in which carbachol remained a full agonist for this response. We interpret our data as indicating that: there is much greater receptor reserve in the coupling of muscarinic receptors to adenylate cyclase than to PI hydrolysis; this, rather than differences in receptor affinity underlies the disparate dose-response relationships for the two responses; and differences in the effects of weak agonist on the two responses may also reflect differences in receptor reserve. We suggest that muscarinic receptors with the same affinity for carbachol interact with different efficiency with the transducers (Gi and Gx) that regulate adenylate cyclase and phospholipase C.

PubMed Disclaimer

Cited by

Differential Desensitization Observed at Multiple Effectors of Somatic μ-Opioid Receptors Underlies Sustained Agonist-Mediated Inhibition of Proopiomelanocortin Neuron Activity.
Fox PD, Hentges ST. Fox PD, et al. J Neurosci. 2017 Sep 6;37(36):8667-8677. doi: 10.1523/JNEUROSCI.1030-17.2017. Epub 2017 Aug 7. J Neurosci. 2017. PMID: 28821664 Free PMC article.
Adenosine Receptor Reserve and Long-Term Potentiation: Unconventional Adaptive Mechanisms in Cardiovascular Diseases?
Guieu R, Brignole M, Deharo JC, Deharo P, Mottola G, Groppelli A, Paganelli F, Ruf J. Guieu R, et al. Int J Mol Sci. 2021 Jul 15;22(14):7584. doi: 10.3390/ijms22147584. Int J Mol Sci. 2021. PMID: 34299203 Free PMC article. Review.
Collision coupling, crosstalk, and compartmentalization in G-protein coupled receptor systems: can a single model explain disparate results?
Brinkerhoff CJ, Traynor JR, Linderman JJ. Brinkerhoff CJ, et al. J Theor Biol. 2008 Dec 7;255(3):278-86. doi: 10.1016/j.jtbi.2008.08.003. Epub 2008 Aug 8. J Theor Biol. 2008. PMID: 18761019 Free PMC article.
Drugs and receptors. An overview of the current state of knowledge.
Kenakin T. Kenakin T. Drugs. 1990 Nov;40(5):666-87. doi: 10.2165/00003495-199040050-00003. Drugs. 1990. PMID: 2292230 Review.
Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life.
Zsuga J, Erdei T, Szabó K, Lampe N, Papp C, Pinter A, Szentmiklosi AJ, Juhasz B, Szilvássy Z, Gesztelyi R. Zsuga J, et al. Molecules. 2017 May 19;22(5):839. doi: 10.3390/molecules22050839. Molecules. 2017. PMID: 28534854 Free PMC article.

Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells - PubMed (original) (raw)